A2M could comfortably double its line for FY18, in fact I am anticipating that it will go close to tripling it should demand and supply work in our favour.
All the points @imback makes are spot on and the fact that the IF margin is extremely strong means that a tripling of the bottom line doesn't require a tripling of revenue. If they double revenue, and granted its a sizeable if, they will triple the bottom line.
If your in doubt, what till Wednesday and pull the financials apart, its not that hard. If you can't wait, pull the FY16 result apart and then factor in price increases, inefficiencies etc. The margin we make on IF is simply beautiful.
Just my humble thoughts however this is merely the beginning as far as I'm concerned.
Cheers
Kosy
A2m - time to short, page-64
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B |
Open | High | Low | Value | Volume |
$4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.83 | 5662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 26112 | 4.800 |
5 | 8198 | 4.790 |
4 | 2409 | 4.780 |
2 | 4629 | 4.770 |
6 | 10700 | 4.760 |
Price($) | Vol. | No. |
---|---|---|
4.840 | 6237 | 1 |
4.850 | 303 | 1 |
4.930 | 10000 | 1 |
4.950 | 2000 | 1 |
4.990 | 6521 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online